Date: 2012-11-13
Type of information: R&D agreement
Compound:
Company: Aptuit (USA) GSK (UK)
Therapeutic area:
Type agreement: R&D
Action mechanism:
Disease:
Details: Aptuit has reached an agreement on a multiyear extension of its strategic partnership with GSK for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy.
The Verona site – formerly known as GSK’s Medicines Research Centre – was acquired by Aptuit from GSK in 2010. During the two years since the Verona site became part of Aptuit it has effectively transitioned to a lean, flexible, customer-focused pharmaceutical services operation. To date, the Verona site has had approximately 50 successful audits and has delivered work for more than 100 clients.
Financial terms:
Latest news:
